Search results
Qsemble Capital Management LP Purchases Shares of 239 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 1 day agoQsemble Capital Management LP acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during ...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...
Simply Wall St. via Yahoo Finance· 5 days agoHowever, on some occasions it makes it more difficult for other shareholders to hold the board...
Regeneron shares rise on Evercore ISI Outperform rating By Investing.com
Investing.com· 2 days agoOn Monday, Evercore ISI initiated coverage on Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc....
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 6 days agoMerit Financial Group LLC lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 53.7% in ...
...You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years - Regeneron...
Benzinga· 21 hours agoRegeneron Pharmaceuticals REGN has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of ...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 2 days agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
TFF Pharmaceuticals (NASDAQ:TFFP) vs. Alnylam Pharmaceuticals (NASDAQ:ALNY) Financial Contrast
ETF DAILY NEWS· 5 days agoAlnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) are both medical companies, but which is ...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks· 5 days agoMaking its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE Quick QuotePBE - Free Report) provides investors broad exposure to the Health Care ETFs ...
Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
Zacks· 5 days agoIntellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company provides developmental and regulatory updates on its pipeline candidates. Stock rises.
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks via Yahoo Finance· 2 days agoLooking at individual holdings, Neurocrine Biosciences Inc (NBIX) accounts for about 5.26% of total...